Májtranszplantáció utáni krónikus C-hepatitis recidívájának kombinált antivirális kezelése.

Translated title of the contribution: Combined antiviral treatment in a patient with recurrent chronic hepatitis C after liver transplantation

Tímea Csák, Anikó Folhoffer, Andrea Horváth, G. Lengyel, L. Kóbori, F. Szalay

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

BACKGROUND: Hepatitis C virus infection persists after liver transplantation and causes recurrent liver injury in the majority of the patients. We report a case of orthotopic liver transplantation with more than five years survival despite the early recurrence of hepatitis C virus. CASE REPORT: A 49-year old woman underwent orthotopic liver transplantation because of liver cirrhosis following chronic hepatitis C virus infection. Twelve years before she received blood-transfusion. The chronic liver disease was diagnosed four years later. However, then it was thought to be a drug induced liver damage. After the liver transplantation hepatitis C chronic hepatitis recurred within one year. The serotype analysis (1b) proved the autoreinfection. The combined antiviral treatment (interferon plus ribavirin) resulted significant improvement. She was asymptomatic nearly for two years. The liver biopsy showed a significant histological improvement. However the virologic response and remission was transient. Four years after the transplantation recurrence occurred again. The liver biopsy proved cirrhosis. Antiviral therapy with pegylated interferon plus ribavirin was started but it had been stopped because of severe cytopenia. Lack of adequate antiviral treatment her condition became progressively worse. Finally, five years after the transplantation she died because of bilateral haemorrhagic ovarian necrosis and severe circulatory insufficiency thanks to the low albumin level. CONCLUSIONS: In the case of liver cirrhosis caused by hepatitis C virus the liver transplantation could prolongs the life with years. The presented case illustrate that the hepatitis C virus injures the transplanted liver by autoreinfection. However, the combined antiviral therapy could result sustained virologic response in these cases as well. Our patient survived five years thanks to the transplantation and the following antiviral therapy.

Original languageHungarian
Pages (from-to)2003-2006
Number of pages4
JournalOrvosi Hetilap
Volume145
Issue number39
Publication statusPublished - Sep 26 2004

Fingerprint

Chronic Hepatitis C
Hepacivirus
Liver Transplantation
Antiviral Agents
Liver
Transplantation
Ribavirin
Virus Diseases
Liver Cirrhosis
Interferons
Biopsy
Therapeutics
Recurrence
Blood Transfusion
Liver Diseases
Albumins
Fibrosis
Chronic Disease
Necrosis
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Májtranszplantáció utáni krónikus C-hepatitis recidívájának kombinált antivirális kezelése. / Csák, Tímea; Folhoffer, Anikó; Horváth, Andrea; Lengyel, G.; Kóbori, L.; Szalay, F.

In: Orvosi Hetilap, Vol. 145, No. 39, 26.09.2004, p. 2003-2006.

Research output: Contribution to journalArticle

@article{87eedbc9de5749b7ac17bffe335157bb,
title = "M{\'a}jtranszplant{\'a}ci{\'o} ut{\'a}ni kr{\'o}nikus C-hepatitis recid{\'i}v{\'a}j{\'a}nak kombin{\'a}lt antivir{\'a}lis kezel{\'e}se.",
abstract = "BACKGROUND: Hepatitis C virus infection persists after liver transplantation and causes recurrent liver injury in the majority of the patients. We report a case of orthotopic liver transplantation with more than five years survival despite the early recurrence of hepatitis C virus. CASE REPORT: A 49-year old woman underwent orthotopic liver transplantation because of liver cirrhosis following chronic hepatitis C virus infection. Twelve years before she received blood-transfusion. The chronic liver disease was diagnosed four years later. However, then it was thought to be a drug induced liver damage. After the liver transplantation hepatitis C chronic hepatitis recurred within one year. The serotype analysis (1b) proved the autoreinfection. The combined antiviral treatment (interferon plus ribavirin) resulted significant improvement. She was asymptomatic nearly for two years. The liver biopsy showed a significant histological improvement. However the virologic response and remission was transient. Four years after the transplantation recurrence occurred again. The liver biopsy proved cirrhosis. Antiviral therapy with pegylated interferon plus ribavirin was started but it had been stopped because of severe cytopenia. Lack of adequate antiviral treatment her condition became progressively worse. Finally, five years after the transplantation she died because of bilateral haemorrhagic ovarian necrosis and severe circulatory insufficiency thanks to the low albumin level. CONCLUSIONS: In the case of liver cirrhosis caused by hepatitis C virus the liver transplantation could prolongs the life with years. The presented case illustrate that the hepatitis C virus injures the transplanted liver by autoreinfection. However, the combined antiviral therapy could result sustained virologic response in these cases as well. Our patient survived five years thanks to the transplantation and the following antiviral therapy.",
author = "T{\'i}mea Cs{\'a}k and Anik{\'o} Folhoffer and Andrea Horv{\'a}th and G. Lengyel and L. K{\'o}bori and F. Szalay",
year = "2004",
month = "9",
day = "26",
language = "Hungarian",
volume = "145",
pages = "2003--2006",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "39",

}

TY - JOUR

T1 - Májtranszplantáció utáni krónikus C-hepatitis recidívájának kombinált antivirális kezelése.

AU - Csák, Tímea

AU - Folhoffer, Anikó

AU - Horváth, Andrea

AU - Lengyel, G.

AU - Kóbori, L.

AU - Szalay, F.

PY - 2004/9/26

Y1 - 2004/9/26

N2 - BACKGROUND: Hepatitis C virus infection persists after liver transplantation and causes recurrent liver injury in the majority of the patients. We report a case of orthotopic liver transplantation with more than five years survival despite the early recurrence of hepatitis C virus. CASE REPORT: A 49-year old woman underwent orthotopic liver transplantation because of liver cirrhosis following chronic hepatitis C virus infection. Twelve years before she received blood-transfusion. The chronic liver disease was diagnosed four years later. However, then it was thought to be a drug induced liver damage. After the liver transplantation hepatitis C chronic hepatitis recurred within one year. The serotype analysis (1b) proved the autoreinfection. The combined antiviral treatment (interferon plus ribavirin) resulted significant improvement. She was asymptomatic nearly for two years. The liver biopsy showed a significant histological improvement. However the virologic response and remission was transient. Four years after the transplantation recurrence occurred again. The liver biopsy proved cirrhosis. Antiviral therapy with pegylated interferon plus ribavirin was started but it had been stopped because of severe cytopenia. Lack of adequate antiviral treatment her condition became progressively worse. Finally, five years after the transplantation she died because of bilateral haemorrhagic ovarian necrosis and severe circulatory insufficiency thanks to the low albumin level. CONCLUSIONS: In the case of liver cirrhosis caused by hepatitis C virus the liver transplantation could prolongs the life with years. The presented case illustrate that the hepatitis C virus injures the transplanted liver by autoreinfection. However, the combined antiviral therapy could result sustained virologic response in these cases as well. Our patient survived five years thanks to the transplantation and the following antiviral therapy.

AB - BACKGROUND: Hepatitis C virus infection persists after liver transplantation and causes recurrent liver injury in the majority of the patients. We report a case of orthotopic liver transplantation with more than five years survival despite the early recurrence of hepatitis C virus. CASE REPORT: A 49-year old woman underwent orthotopic liver transplantation because of liver cirrhosis following chronic hepatitis C virus infection. Twelve years before she received blood-transfusion. The chronic liver disease was diagnosed four years later. However, then it was thought to be a drug induced liver damage. After the liver transplantation hepatitis C chronic hepatitis recurred within one year. The serotype analysis (1b) proved the autoreinfection. The combined antiviral treatment (interferon plus ribavirin) resulted significant improvement. She was asymptomatic nearly for two years. The liver biopsy showed a significant histological improvement. However the virologic response and remission was transient. Four years after the transplantation recurrence occurred again. The liver biopsy proved cirrhosis. Antiviral therapy with pegylated interferon plus ribavirin was started but it had been stopped because of severe cytopenia. Lack of adequate antiviral treatment her condition became progressively worse. Finally, five years after the transplantation she died because of bilateral haemorrhagic ovarian necrosis and severe circulatory insufficiency thanks to the low albumin level. CONCLUSIONS: In the case of liver cirrhosis caused by hepatitis C virus the liver transplantation could prolongs the life with years. The presented case illustrate that the hepatitis C virus injures the transplanted liver by autoreinfection. However, the combined antiviral therapy could result sustained virologic response in these cases as well. Our patient survived five years thanks to the transplantation and the following antiviral therapy.

UR - http://www.scopus.com/inward/record.url?scp=16544367702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16544367702&partnerID=8YFLogxK

M3 - Article

C2 - 15553912

AN - SCOPUS:16544367702

VL - 145

SP - 2003

EP - 2006

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 39

ER -